TABLE 3.

Exploratory analyses for different vaccine types

Cohorts	ChAdOx1			BNT162b2
	No. of cases/people	Incidence rate (95% CI) a	Adjusted hazard ratio (95% CI) b	No. of cases/people	Incidence rate (95% CI) a	Adjusted hazard ratio (95% CI) b
28 days after one dose	25/138 059	0.65 (0.42–0.96)	1.45 (0.99–2.13)	33/83 816	1.41 (0.97–1.98)	1.38 (0.99–1.93)
90 days after one dose	94/138 059	0.76 (0.61–0.93)	1.63 (1.34–1.98)	99/83 816	1.31 (1.07–1.60)	1.24 (1.02–1.50)
28 days after two doses	30/136 002	0.79 (0.53–1.13)	1.24 (0.88–1.77)	26/80 709	1.15 (0.75–1.69)	1.20 (0.82–1.76)
90 days after two doses	100/136 002	0.82 (0.67–1.00)	1.53 (1.27–1.85)	87/80 709	1.20 (0.96–1.48)	1.22 (1.00–1.51)

^a PER 100 000 person‐days.

^b PER 1‐SD increase of PRS.